| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | ADALIMUMAB-AATY | 4 |
| 2 | ADALIMUMAB-ADAZ | 4 |
| 3 | ADALIMUMAB-FKJP | 4 |
| 4 | INFLIXIMAB | 4 |
| 5 | ALPRAZOLAM | 3 |
| 6 | ATAZANAVIR | 3 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 3 |
| 8 | MYCOPHENOLATE MOFETIL | 3 |
| 9 | RITONAVIR | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | 1 | 0.0114 |
| 1 | GRISEOFULVIN | 1 | 0.0034 |
| 2 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 3 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 1 | 0.0003 |
| 4 | LAMIVUDINE AND ZIDOVUDINE | 2 | 0.0003 |
| 5 | ACARBOSE | 1 | 0.0003 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 7 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | ATAZANAVIR | 3 | 0.0002 |
| 9 | RITONAVIR 100 MG | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |